Drug Abuse: An Exploration of the Government's Use of Mefloquine at Guantanamo

Seton Hall University School of Law Center for Policy & Research Paper No. 2010-33

32 Pages Posted: 24 May 2011 Last revised: 31 May 2011

See all articles by Mark Denbeaux

Mark Denbeaux

Seton Hall Law School

Sean August Camoni

affiliation not provided to SSRN

Brian Beroth

affiliation not provided to SSRN

Mehgan Chrisner

affiliation not provided to SSRN

Chrystal Loyer

Seton Hall University, School of Law '13

Paul W. Taylor

Seton Hall University - School of Law - Center for Policy & Research

Kelli Stout

affiliation not provided to SSRN

Date Written: May 19, 2011

Abstract

Mefloquine is an antimalarial drug that has long been known to cause severe neuropsychological adverse effects such as anxiety, paranoia, hallucinations, aggression, psychotic behavior, mood changes, depression, memory impairment, convulsions, loss of coordination (ataxia), suicidal ideation, and possibly suicide, particularly in patients with a history of mental illness. A prescribing physician must exercise caution and informed judgment when weighing the risks and potential benefits of prescribing the drug. To administer this drug with its severe potential side effects without a malaria diagnosis and without taking a patient’s mental health history is not medically justified. Yet as a matter of official policy, the standard operating procedure implemented by the United States military at Guantanamo Bay was to administer high doses of mefloquine to detainees whether or not any use of the drug was medically appropriate and without consideration of the detainees’ mental health. It is clear that the military employed a medically inappropriate treatment regime at Guantanamo Bay (GTMO). It is less clear why, although the available evidence supports several possible conclusions. In view of the continued and unexplained refusal of the government to release full medical records for all detainees, it is not possible to determine whether this conduct was gross malpractice or deliberate misuse of drug. In either case, it does not appear plausible from the available evidence that mefloquine was given to treat malaria. This suggests a darker possibility: that the military gave detainees the drug specifically to bring about the adverse side effects, either as part of enhanced interrogation techniques, experimentation in behavioral modification, or torture for some other purpose. While this Report does not reach a conclusion about the actual conduct, it does explore the legal rules that would apply were it determined that mefloquine was administered not to treat malaria but rather to exploit the neuropsychiatric effects of the drug.

Keywords: Guantanamo, torture, detention, medicine, treatment, medical experimentation, bioethics, physicians, doctors, malaria, mefloquine, hallucination, disorientation, suicide, mental health, interrogation, malpractice, behavioral modification, drug, physician, doctor

Suggested Citation

Denbeaux, Mark and Camoni, Sean August and Beroth, Brian and Chrisner, Mehgan and Loyer, Chrystal and Taylor, Paul W. and Stout, Kelli, Drug Abuse: An Exploration of the Government's Use of Mefloquine at Guantanamo (May 19, 2011). Seton Hall University School of Law Center for Policy & Research Paper No. 2010-33, Available at SSRN: https://ssrn.com/abstract=1846784

Mark Denbeaux (Contact Author)

Seton Hall Law School ( email )

One Newark Center
Newark, NJ 07102-5210
United States

Sean August Camoni

affiliation not provided to SSRN ( email )

Brian Beroth

affiliation not provided to SSRN

Mehgan Chrisner

affiliation not provided to SSRN

Chrystal Loyer

Seton Hall University, School of Law '13 ( email )

One Newark Center
Newark, NJ 07102-5210
United States

Paul W. Taylor

Seton Hall University - School of Law - Center for Policy & Research ( email )

One Newark Center
Newark, NJ 07102-5210
United States

Kelli Stout

affiliation not provided to SSRN ( email )

Do you have negative results from your research you’d like to share?

Paper statistics

Downloads
203
Abstract Views
1,903
Rank
269,880
PlumX Metrics